We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Teradata
TDC
$2.91B
| – | – |
-10,893
| Closed | -$403K |
|
1152
TE Connectivity
TEL
$60.4B
| – | – |
-24,200
| Closed | -$1.56M |
|
1153
Teradyne
TER
$58.2B
| – | – |
-23,525
| Closed | -$454K |
|
1154
Teva Pharmaceuticals
TEVA
$40.8B
| – | – |
-200,452
| Closed | -$11.8M |
|
1155
Terex
TEX
$7.24B
| – | – |
-12,468
| Closed | -$290K |
|
1156
TIM SA
TIMB
$9.23B
| – | – |
-743,225
| Closed | -$12.2M |
|
1157
Timken Company
TKR
$9.57B
| – | – |
-7,957
| Closed | -$291K |
|
1158
Thermo Fisher Scientific
TMO
$212B
| – | – |
-4,200
| Closed | -$545K |
|
|
TPH
1159
DELISTED
Tri Pointe Homes
TPH
| – | – |
-14,108
| Closed | -$216K |
|
1160
Tapestry
TPR
$30.8B
| – | – |
-9,174
| Closed | -$318K |
|
1161
Thomson Reuters
TRI
$42.9B
| – | – |
-7,062
| Closed | -$312K |
|
1162
T. Rowe Price
TROW
$24.1B
| – | – |
-13,561
| Closed | -$1.05M |
|
1163
Travelers Companies
TRV
$79B
| – | – |
-255,940
| Closed | -$22.7M |
|
1164
Tetra Tech
TTEK
$8.44B
| – | – |
-58,785
| Closed | -$301K |
|
1165
Texas Instruments
TXN
$252B
| – | – |
-15,984
| Closed | -$823K |
|
1166
United Airlines
UAL
$39.7B
| – | – |
-20,420
| Closed | -$1.08M |
|
1167
United Bankshares
UBSI
$6.61B
| – | – |
-18,688
| Closed | -$752K |
|
1168
Upbound Group
UPBD
$1.14B
| – | – |
-10,448
| Closed | -$296K |
|
1169
United Parcel Service
UPS
$88.7B
| – | – |
-18,176
| Closed | -$1.76M |
|
1170
United Therapeutics
UTHR
$25.9B
| – | – |
-2,200
| Closed | -$383K |
|
1171
Universal Corp
UVV
$1.32B
| – | – |
-4,900
| Closed | -$281K |
|
1172
Vipshop
VIPS
$7.33B
| – | – |
-63,700
| Closed | -$1.42M |
|
1173
Valero Energy
VLO
$91B
| – | – |
-30,919
| Closed | -$1.94M |
|
1174
Valley National Bancorp
VLY
$7.89B
| – | – |
-14,200
| Closed | -$146K |
|
|
VNET
1175
VNET Group
VNET
$2.03B
| – | – |
-117,821
| Closed | -$2.42M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.